Burzynski Research Institute, Inc.
BZYR · OTC
11/30/2025 | 8/31/2025 | 5/31/2025 | 2/28/2025 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | -0.23 | 0.35 |
| FCF Yield | -14.23% | -2.78% | -1.21% | -0.61% |
| EV / EBITDA | -17.58 | -10.23 | -12.29 | -11.48 |
| Quality | ||||
| ROIC | 488.34% | 479.89% | 475.43% | 703.22% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | – | -0.29 | 0.15 | 0.16 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -767.28% | -93.12% | -5.04% | 65.12% |
| Safety | ||||
| Net Debt / EBITDA | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |